DiaMedica Therapeutics (DMAC) Tax Provisions (2018 - 2026)
DiaMedica Therapeutics (DMAC) posted quarterly Tax Provisions of $7000.0 for Q1 2026, up 16.67% year-over-year from $6000.0 in Q1 2025, and up 100.14% quarter-over-quarter from -$4.9 million in Q4 2025.
DiaMedica Therapeutics (DMAC) Tax Provisions (2018 - 2026) Analysis & Trends
DiaMedica Therapeutics' Tax Provisions history runs 9 years deep, the most recent figure standing at $7000.0 for Q1 2026.
- In Q1 2026, Tax Provisions rose 16.67% year-over-year to $7000.0; the TTM figure through Mar 2026 stood at -$4.9 million (down 17031.03% YoY), while the FY2025 annual figure was -$4.9 million, down 16470.0% from the prior year.
- Tax Provisions for Q1 2026 stood at $7000.0, up from -$4.9 million in the prior quarter.
- The five-year high for Tax Provisions was $22000.0 in Q4 2023, with the low at -$4.9 million in Q4 2025.
- The 5-year median for Tax Provisions is $7000.0 (2022), against an average of -$282529.4.
- The sharpest annual moves came in 2023 and 2025: Tax Provisions surged 214.29% in 2023, then tumbled 54866.67% in 2025.
- DiaMedica Therapeutics' Tax Provisions stood at $7000.0 in 2022, then soared by 214.29% to $22000.0 in 2023, then tumbled by 59.09% to $9000.0 in 2024, then sank by 54866.67% to -$4.9 million in 2025, then jumped by 100.14% to $7000.0 in 2026.
- Business Quant data shows DMAC's Tax Provisions at $7000.0 in Q1 2026, -$4.9 million in Q4 2025, and $6000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | DiaMedica Therapeutics | 360.22 Mn | 360.22 Mn | - | 7,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7,000.00 |
| Mar 31, 2026 | 7,000.00 |
| Dec 31, 2025 | -4.93 Mn |
| Sep 30, 2025 | 6,000.00 |
| Jun 30, 2025 | 6,000.00 |
| Mar 31, 2025 | 6,000.00 |
| Dec 31, 2024 | 9,000.00 |
| Sep 30, 2024 | 7,000.00 |
| Jun 30, 2024 | 7,000.00 |
| Mar 31, 2024 | 7,000.00 |
| Dec 31, 2023 | 22,000.00 |
| Sep 30, 2023 | 7,000.00 |
| Jun 30, 2023 | 7,000.00 |
| Mar 31, 2023 | 7,000.00 |
| Dec 31, 2022 | 7,000.00 |
| Sep 30, 2022 | 7,000.00 |
| Jun 30, 2022 | 7,000.00 |
| Mar 31, 2022 | 7,000.00 |
| Dec 31, 2021 | 7,000.00 |
| Sep 30, 2021 | 7,000.00 |